ArticleCancer management and research2018

The high pCR rate of sandwich neoadjuvant treatment in locally advanced rectal cancer may translate into a better long-term survival benefit: 5-year outcome of a Phase II clinical trial.

Yong-Hong Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.